Drug Type: Anti-inflammatory

Betamethasone

Betamethasone is a long-acting corticosteroid with immunosuppressive and antiinflammatory properties. It has been used to treat gout in chickens and degenerative hip disorders in turkeys.
  • 0.04-0.1 mg/kg IM
pill, injectable
  • Increased susceptibility to infections
  • Acetylsalicylic acid (Asprin): The risk or severity of adverse effects can be increased when Betamethasone is combined with Acetylsalicylic acid.
  • Albendazole:The metabolism of Albendazole can be increased when combined with Betamethasone.
  • Bismuth subsalicylate:The serum concentration of Betamethasone can be decreased when it is combined with Bismuth subsalicylate.
  • Carprofen: The risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Carprofen.
  • Chloramphenicol:The risk or severity of adverse effects can be increased when Betamethasone is combined with Chloramphenicol.
  • Dexamethasone:The risk or severity of adverse effects can be increased when Betamethasone is combined with Dexamethasone.
  • Diazepam:The metabolism of Diazepam can be increased when combined with Betamethasone.
  • Enalapril: The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Betamethasone is combined with Enalapril.
  • Enrofloxacin:The risk or severity of tendinopathy can be increased when Betamethasone is combined with Enrofloxacin.
  • Firocoxib:The risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Firocoxib.
  • Isoflurane:The metabolism of Isoflurane can be increased when combined with Betamethasone.
  • Ivermectin:The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Betamethasone is combined with Ivermectin.
  • Ketoprofen:The risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Ketoprofen.
  • Meloxicam:The risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Meloxicam.
  • Methylprednisolone:The risk or severity of adverse effects can be increased when Betamethasone is combined with Methylprednisolone.
  • Praziquantel: The metabolism of Praziquantel can be increased when combined with Betamethasone.
  • Prednisolone:The risk or severity of adverse effects can be increased when Betamethasone is combined with Prednisolone.
  • Pyrantel:The risk or severity of myopathy and weakness can be increased when Pyrantel is combined with Betamethasone.
  • Salicylic acid:The risk or severity of gastrointestinal irritation can be increased when Salicylic acid is combined with Betamethasone.
  • Tilmicosin:The serum concentration of Betamethasone can be increased when it is combined with Tilmicosin.
  • Tylosin:The serum concentration of Betamethasone can be increased when it is combined with Tylosin.
  • Vitamin D:The therapeutic efficacy of Vitamin D can be decreased when used in combination with Betamethasone.

Popular Health Tools

Switch Animal